These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16783046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
    Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM.
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report.
    Joshi SN, Dutta S, Kumar BK, Katti U, Kulkarni S, Risbud A, Mehendale S.
    Sex Transm Infect; 2008 Oct; 84(5):343-7. PubMed ID: 18426844
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S, Joglekar N, Ghate M, Unni J, Risbud A, Bentley M, Shepherd M, Bollinger R, Mehendale S.
    Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303
    [Abstract] [Full Text] [Related]

  • 8. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, Mâsse B, Soto-Torres L, Kwiecien A.
    AIDS; 2006 May 12; 20(8):1109-16. PubMed ID: 16691061
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 12; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 10. A polyherbal vaginal pessary with spermicidal and antimicrobial action: evaluation of its safety.
    Bagga R, Raghuvanshi P, Gopalan S, Das SK, Baweja R, Suri S, Malhotra D, Khare S, Talwar GP.
    Trans R Soc Trop Med Hyg; 2006 Dec 12; 100(12):1164-7. PubMed ID: 16750546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.
    Sahin-Hodoglugil NN, Montgomery E, Kacanek D, Morar N, Mtetwa S, Nkala B, Philip J, Ramjee G, Cheng H, van der Straten A, The Mira Team.
    AIDS Care; 2011 Aug 12; 23(8):1026-34. PubMed ID: 21480005
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov 12; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 15. Microbicide preference among young women in California.
    Holt BY, Morwitz VG, Ngo L, Harrison PF, Whaley KJ, Pettifor A, Nguyen AH.
    J Womens Health (Larchmt); 2006 Apr 12; 15(3):281-94. PubMed ID: 16620187
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial comparing a polyherbal pessary (a complementary and alternative medicine) with Ginlac-V pessary (containing clotrimazole, tinidazole and lactobacilli) for treatment of women with symptomatic vaginal discharge.
    Patel Y, Gopalan S, Bagga R, Sharma M, Chopra S, Sethi S.
    Arch Gynecol Obstet; 2008 Oct 12; 278(4):341-7. PubMed ID: 18236058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 Oct 12; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 19. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA, Friedland BA, Morar NS, Katzen LL, Ramjee G, Mokgatle MM, Ahmed K.
    Cult Health Sex; 2015 Oct 12; 17(8):1004-20. PubMed ID: 25913101
    [Abstract] [Full Text] [Related]

  • 20. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun 12; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.